Pembrolizumab in Combination with Bevacizumab and Pegylated Liposomal Doxorubicin in Patients with Ovarian Cancer
Clinical trial NCT03596281 · COMPLETED
Trial details
- NCT number
- NCT03596281
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-05
- Primary completion
- 2021-03-11
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.